Literature DB >> 24061282

Efficacy and limitations of a STEMI network: 3 years of experience within the myocardial infarction network of the region of Augsburg - HERA.

Christian Thilo1, Andreas Blüthgen, Wolfgang von Scheidt.   

Abstract

AIMS: The HERA Registry investigates logistics, adherence to standards, time intervals, and mortality in a regional network for primary percutaneous coronary intervention (PPCI) in ST-elevation myocardial infarction (STEMI) in a mixed urban and rural area. METHODS AND
RESULTS: We included 826 consecutive patients (pts) within the HERA network with its dedicated PPCI strategy (female n = 243, mean age 64 years, range 25-98 years) with acute STEMI (May 2007 until January 2010). 680 pts (82 %) received PPCI and 45 (5.4 %) acute bypass surgery. Of 512 pts seen by an emergency physician (EP) as first medical contact (FMC) 87 % received on-scene 12-lead ECG. ECG transmission rate to the PPCI center was 29 %. Median FMC-to-balloon time (CBT) was 135 min and door-to-balloon time (DBT) 70 min. With EP FMC DBT was 38 min with direct transfer to cath lab (n = 70), 69 min via ICU (n = 240), and 132 min via ER (n = 91, p < 0.01). Out of 826 pts, 143(17.3 %) presented in cardiogenic shock. In-hospital mortality was 8.8 % (n = 73), 35.7 % for shock pts versus 3.2 % for non-shock pts (p < 0.01). For pts receiving PPCI, in-hospital mortality was 6.2 %, for shock pts (n = 107) 28.0 %, and for non-shock pts (n = 573) 2.1 % (p < 0.01).
CONCLUSION: Prehospital management, CBT and DBT compare favourably to data from studies and registries, but do not yet fulfill strict guideline requirements. Real world mortality in non-shock pts is very low. Direct transfer to cath lab reduces DBTs by 49 %. For this crucial improvement, transmission of a 12-lead ECG to the PPCI center is mandatory.

Entities:  

Mesh:

Year:  2013        PMID: 24061282     DOI: 10.1007/s00392-013-0608-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  41 in total

1.  Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction.

Authors:  Erik Björklund; Ulf Stenestrand; Johan Lindbäck; Leif Svensson; Lars Wallentin; Bertil Lindahl
Journal:  Eur Heart J       Date:  2006-04-19       Impact factor: 29.983

2.  System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).

Authors:  Peter H Nielsen; Christian J Terkelsen; Torsten T Nielsen; Leif Thuesen; Lars R Krusell; Per Thayssen; Henning Kelbaek; Ulrik Abildgaard; Anton B Villadsen; Henning R Andersen; Michael Maeng
Journal:  Am J Cardiol       Date:  2011-07-15       Impact factor: 2.778

3.  Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre.

Authors:  Ulrike M Müller; Ingo Eitel; Kristina Eckrich; Sandra Erbs; Axel Linke; Sven Möbius-Winkler; Meinhard Mende; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-10-24       Impact factor: 5.460

4.  Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.

Authors:  Kim A Eagle; Brahmajee K Nallamothu; Rajendra H Mehta; Christopher B Granger; Philippe Gabriel Steg; Frans Van de Werf; Jose López-Sendón; Shaun G Goodman; Ann Quill; Keith A A Fox
Journal:  Eur Heart J       Date:  2008-03       Impact factor: 29.983

5.  Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.

Authors:  Uwe Zeymer; Hans-Richard Arntz; Bernd Mark; Stephan Fichtlscherer; Gerald Werner; Ralph Schöller; Ralf Zahn; Frank Diller; Harald Darius; Thorsten Dill; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

6.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

7.  In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte.

Authors:  R Zahn; A Vogt; U Zeymer; A K Gitt; K Seidl; M Gottwik; M A Weber; W Niederer; B Mödl; H-J Engel; U Tebbe; J Senges
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

8.  Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.

Authors:  Eric Bonnefoy; Philippe Gabriel Steg; Florent Boutitie; Pierre-Yves Dubien; Frédéric Lapostolle; Jérome Roncalli; Frederic Dissait; Gérald Vanzetto; Alain Leizorowicz; Gilbert Kirkorian; C Mercier; E P McFadden; P Touboul
Journal:  Eur Heart J       Date:  2009-05-08       Impact factor: 29.983

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR).

Authors:  Uwe Zeymer; Hans-Richard Arntz; Burkhardt Dirks; Klaus Ellinger; Harald Genzwürker; Lutz Nibbe; Ulrich Tebbe; Jochen Senges; Steffen Schneider
Journal:  Resuscitation       Date:  2009-01-22       Impact factor: 5.262

View more
  3 in total

1.  Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.

Authors:  Vincent G Haver; Minke H T Hartman; Irene Mateo Leach; Erik Lipsic; Chris P Lexis; Dirk J van Veldhuisen; Wiek H van Gilst; Iwan C van der Horst; Pim van der Harst
Journal:  Clin Res Cardiol       Date:  2015-04-04       Impact factor: 5.460

2.  System dynamics modeling in the evaluation of delays of care in ST-segment elevation myocardial infarction patients within a tiered health system.

Authors:  Luciano de Andrade; Catherine Lynch; Elias Carvalho; Clarissa Garcia Rodrigues; João Ricardo Nickenig Vissoci; Guttenberg Ferreira Passos; Ricardo Pietrobon; Oscar Kenji Nihei; Maria Dalva de Barros Carvalho
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

3.  Impact of the Type of First Medical Contact within a Guideline-Conform ST-Elevation Myocardial Infarction Network: A Prospective Observational Registry Study.

Authors:  Roman Pfister; Samuel Lee; Kathrin Kuhr; Frank Baer; Wolfgang Fehske; Hans-Wilhelm Hoepp; Stephan Baldus; Guido Michels
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.